Fast, hungry and unstable: finding the Achilles’ heel of small-cell lung cancer

This publication has 88 references indexed in Scilit:

• Randomized Phase II Study of Carboplatin and Etoposide With or Without thebcl-2Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103
  Journal of Clinical Oncology, 2008
• Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study
  Investigational New Drugs, 2006
• Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts.
  Clinical Cancer Research, 2006
• Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer
  Lung Cancer, 2005
• Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
  Journal of Clinical Oncology, 2003
• Chromosomal imbalances in human lung cancer
  Oncogene, 2002
• Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571
  Oncogene, 2000
• CLINICAL IMPLICATIONS OF THE p53 GENE
  Annual Review of Medicine, 1996
• Thalidomide is an inhibitor of angiogenesis.
  Proceedings of the National Academy of Sciences, 1994
• Telomeres shorten during ageing of human fibroblasts
  Nature, 1990